Hybrid Cell Line Formed Between T4 Lymphocytes And Tumoral Lymphoid Type Cells Read more about Hybrid Cell Line Formed Between T4 Lymphocytes And Tumoral Lymphoid Type Cells US Patent 5,550,052Filed on 1992-09-11
Hybrid Cell Line Formed Between T4 Lymphocytes And Tumoral Lymphoid Type Cells Read more about Hybrid Cell Line Formed Between T4 Lymphocytes And Tumoral Lymphoid Type Cells US Application 07/632,405Filed on 1990-12-20
Hybrid Cell Line Formed Between T4 Lymphocytes And Tumoral Lymphoid Type Cells Read more about Hybrid Cell Line Formed Between T4 Lymphocytes And Tumoral Lymphoid Type Cells US Application 07/221,303Filed on 1988-07-09
Broadly Cross-Reactive HIV Neutralizing Human Monoclonal Antibodies Read more about Broadly Cross-Reactive HIV Neutralizing Human Monoclonal Antibodies Australia2005302416Filed on 2005-10-28
Broadly Cross-Reactive HIV-1 Neutralizing Human Monoclonal Antibodies Read more about Broadly Cross-Reactive HIV-1 Neutralizing Human Monoclonal Antibodies European Patent05819487.9Filed on 2005-10-28
Broadly Cross-Reactive HIV Neutralizing Human Monoclonal Antibodies Read more about Broadly Cross-Reactive HIV Neutralizing Human Monoclonal Antibodies Canada2585574Filed on 2005-10-28
Broadly Cross-reactive HIV -1 Neutralizing Human Monoclonal Antibodies Read more about Broadly Cross-reactive HIV -1 Neutralizing Human Monoclonal Antibodies US Application 11/718,202Filed on 2007-08-10
A32 Monoclonal Antibody Fusion Proteins For Use As HIV Inhibitors And Vaccines Read more about A32 Monoclonal Antibody Fusion Proteins For Use As HIV Inhibitors And Vaccines US Application 11/577,237Filed on 2007-04-26
Hybrid Cell Line Formed Between T4 Lymphocytes And Tumoral Lymphoid Type Cells Read more about Hybrid Cell Line Formed Between T4 Lymphocytes And Tumoral Lymphoid Type Cells US Application 06/852,438Filed on 1986-04-15
Methods for the preparation of hybridomas producing lymphadenopathy-associated virus (LAV) GP110-specific monoclonal antibodies and methods for the purification of GP110 employing said monoclonal antibodies Read more about Methods for the preparation of hybridomas producing lymphadenopathy-associated virus (LAV) GP110-specific monoclonal antibodies and methods for the purification of GP110 employing said monoclonal antibodies US Patent 5,610,035Filed on 1994-09-27